CV Sciences (CVSI) Goodwill & Intangibles (2012 - 2026)
CV Sciences (CVSI) reported Goodwill & Intangibles of $1.1 million for Q1 2026, down 3.17% on a YoY basis from $1.1 million in Q1 2025, and down 2.02% sequentially from $1.1 million in Q4 2025.
CV Sciences (CVSI) Goodwill & Intangibles (2012 - 2026) Analysis & Trends
CV Sciences (CVSI) has 15 years of Goodwill & Intangibles data on file, last reported at $1.1 million in Q1 2026.
- For the quarter ending Q1 2026, Goodwill & Intangibles fell 3.17% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (down 3.17% YoY), and the FY2025 full-year result was $1.1 million, up 2.54% from the prior year.
- Goodwill & Intangibles slipped to $1.1 million in Q1 2026, from $1.1 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $1.5 million in Q1 2022 to a low of $251000.0 in Q4 2022.
- A 5-year average of $851000.0 and a median of $1.1 million in 2024 frame the typical range for Goodwill & Intangibles.
- Across the five-year window, Goodwill & Intangibles plunged 83.1% in 2022 and jumped 239.84% in 2024, its largest moves.
- Tracing CVSI's Goodwill & Intangibles over 5 years: stood at $251000.0 in 2022, then soared by 67.33% to $420000.0 in 2023, then surged by 153.33% to $1.1 million in 2024, then grew by 2.54% to $1.1 million in 2025, then slipped by 2.02% to $1.1 million in 2026.
- Business Quant data shows CVSI's Goodwill & Intangibles at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.48 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | CV Sciences | 4.11 Mn | 3.80 Mn | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.07 Mn |
| Dec 31, 2025 | 1.09 Mn |
| Sep 30, 2025 | 1.13 Mn |
| Jun 30, 2025 | 1.10 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 1.06 Mn |
| Sep 30, 2024 | 853,000.00 |
| Jun 30, 2024 | 767,000.00 |
| Mar 31, 2024 | 413,000.00 |
| Dec 31, 2023 | 420,000.00 |
| Sep 30, 2023 | 251,000.00 |
| Jun 30, 2023 | 251,000.00 |
| Mar 31, 2023 | 251,000.00 |
| Dec 31, 2022 | 251,000.00 |
| Sep 30, 2022 | 1.49 Mn |
| Jun 30, 2022 | 1.49 Mn |
| Mar 31, 2022 | 1.49 Mn |
| Dec 31, 2021 | 1.49 Mn |
| Sep 30, 2021 | 6.52 Mn |
| Jun 30, 2021 | 6.52 Mn |